Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome.
作者信息
Grant Nathan
机构信息
Department of Molecular and Cellular Biology, Department of Anthropology, Harvard University, Cambridge, MA, USA.
出版信息
Mol Genet Metab Rep. 2020 Jan 16;22:100566. doi: 10.1016/j.ymgmr.2020.100566. eCollection 2020 Mar.
Abstract
摘要
相似文献
1
Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome.
Mol Genet Metab Rep. 2020 Jan 16;22:100566. doi: 10.1016/j.ymgmr.2020.100566. eCollection 2020 Mar.
2
Response to: Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome.
Mol Genet Metab Rep. 2020 Feb 4;22:100570. doi: 10.1016/j.ymgmr.2020.100570. eCollection 2020 Mar.
3
The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome.
Mol Genet Metab Rep. 2019 Dec 20;22:100549. doi: 10.1016/j.ymgmr.2019.100549. eCollection 2020 Mar.
4
Clinical characteristics and somatic burden of patients with mucopolysaccharidosis II with or without neurological involvement: An analysis from the Hunter Outcome Survey.
Mol Genet Metab Rep. 2023 Sep 8;37:101005. doi: 10.1016/j.ymgmr.2023.101005. eCollection 2023 Dec.
5
Natural history of extensive Mongolian spots in mucopolysaccharidosis type II (Hunter syndrome): a survey among 52 Japanese patients.
J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1082-5. doi: 10.1111/j.1468-3083.2007.02203.x.
6
Genotype-phenotype relationship in mucopolysaccharidosis II: predictive power of IDS variants for the neuronopathic phenotype.
Dev Med Child Neurol. 2017 Oct;59(10):1063-1070. doi: 10.1111/dmcn.13467. Epub 2017 May 25.
7
Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl.
BMC Med Genet. 2019 May 2;20(1):66. doi: 10.1186/s12881-019-0807-x.
8
Recovery of Vision following Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II, Hunter Syndrome.
Case Rep Ophthalmol. 2019 Jun 6;10(2):186-194. doi: 10.1159/000500804. eCollection 2019 May-Aug.
9
Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).
Pediatrics. 2008 Feb;121(2):e377-86. doi: 10.1542/peds.2007-1350.
10
Initial report from the Hunter Outcome Survey.
Genet Med. 2008 Jul;10(7):508-16. doi: 10.1097/gim.0b013e31817701e6.
引用本文的文献
1
Evaluating strategies to manage and endure challenging behaviors in mucopolysaccharidoses.
Orphanet J Rare Dis. 2021 Apr 8;16(1):165. doi: 10.1186/s13023-021-01767-8.
2
Response to: Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome.
Mol Genet Metab Rep. 2020 Feb 4;22:100570. doi: 10.1016/j.ymgmr.2020.100570. eCollection 2020 Mar.
本文引用的文献
1
The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome.
Mol Genet Metab Rep. 2019 Dec 20;22:100549. doi: 10.1016/j.ymgmr.2019.100549. eCollection 2020 Mar.
2
Sibling and family caregivers.
BMJ. 2018 Aug 1;362:k3158. doi: 10.1136/bmj.k3158.
3
Management of the behavioural manifestations of Hunter syndrome.
Br J Nurs. 2016;25(1):22, 24, 26-30. doi: 10.12968/bjon.2016.25.1.22.
4
Natural progression of neurological disease in mucopolysaccharidosis type II.
Pediatrics. 2011 May;127(5):e1258-65. doi: 10.1542/peds.2010-1274. Epub 2011 Apr 25.
Zotero 插件